Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Women's preferences for cancer risk management strategies in Lynch syndrome.

Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK.

Gynecol Oncol. 2019 Mar;152(3):514-521. doi: 10.1016/j.ygyno.2018.11.027.

PMID:
30876497
2.

Frequency of Germline BRCA1/2 Mutations in Unselected Patients With Colorectal Cancer.

Daniels MS, Bannon SA, Mork ME.

J Clin Oncol. 2017 Aug 1;35(22):2588. doi: 10.1200/JCO.2017.72.7222. Epub 2017 May 16. No abstract available.

PMID:
28510492
3.

Genetic predisposition in gynecologic cancers.

Daniels MS, Lu KH.

Semin Oncol. 2016 Oct;43(5):543-547. doi: 10.1053/j.seminoncol.2016.08.005. Epub 2016 Sep 20. Review.

PMID:
27899185
4.

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.

Ring KL, Bruegl AS, Allen BA, Elkin EP, Singh N, Hartman AR, Daniels MS, Broaddus RR.

Mod Pathol. 2016 Nov;29(11):1381-1389. doi: 10.1038/modpathol.2016.135. Epub 2016 Jul 22.

5.

Clearer picture of PMS2-associated lynch syndrome is emerging.

Daniels MS, Lu KH.

J Clin Oncol. 2015 Feb 1;33(4):299-300. doi: 10.1200/JCO.2014.58.9796. Epub 2014 Dec 22. No abstract available.

PMID:
25534383
6.

Reply to D. Braun et al.

Daniels MS, Lu KH.

J Clin Oncol. 2014 Nov 10;32(32):3683. doi: 10.1200/JCO.2014.57.6124. Epub 2014 Sep 8. No abstract available.

PMID:
25199758
7.

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.

Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R, Fellman BM, Lu KH, Broaddus RR.

Gynecol Oncol. 2014 Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14.

8.

Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.

Daniels MS, Babb SA, King RH, Urbauer DL, Batte BA, Brandt AC, Amos CI, Buchanan AH, Mutch DG, Lu KH.

J Clin Oncol. 2014 Apr 20;32(12):1249-55. doi: 10.1200/JCO.2013.50.6055. Epub 2014 Mar 17.

9.

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.

Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH.

Gynecol Oncol. 2014 May;133(2):283-6. doi: 10.1016/j.ygyno.2014.02.030. Epub 2014 Feb 28.

10.

Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM.

Nat Genet. 2014 Feb;46(2):182-7. doi: 10.1038/ng.2855. Epub 2013 Dec 22.

11.

Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.

Daniels MS, Urbauer DL, Zangeneh A, Batte BA, Dempsey KM, Lu KH.

Gynecol Oncol. 2013 Dec;131(3):619-23. doi: 10.1016/j.ygyno.2013.10.011. Epub 2013 Oct 17.

12.

Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.

Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen LM, Lynch H, Cornelison T, Boyd-Rogers S, Rubin M, Daniels MS, Conrad P, Milbourne A, Gershenson DM, Broaddus RR.

Cancer Prev Res (Phila). 2013 Aug;6(8):774-81. doi: 10.1158/1940-6207.CAPR-13-0020. Epub 2013 May 2.

13.

Genetic testing by cancer site: uterus.

Daniels MS.

Cancer J. 2012 Jul-Aug;18(4):338-42. doi: 10.1097/PPO.0b013e3182610cc2. Review.

PMID:
22846735
14.

Lifetime cancer risks of PTEN mutation carriers--letter.

Daniels MS, Rich T, Weissman S, Pilarski R.

Clin Cancer Res. 2012 Aug 1;18(15):4213; author reply 4214. doi: 10.1158/1078-0432.CCR-12-0577. Epub 2012 Jun 21. No abstract available.

15.

Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.

Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC.

Cancer. 2011 Jun 15;117(12):2659-67. doi: 10.1002/cncr.25820. Epub 2010 Dec 29.

16.

Testing women with endometrial cancer to detect Lynch syndrome.

Kwon JS, Scott JL, Gilks CB, Daniels MS, Sun CC, Lu KH.

J Clin Oncol. 2011 Jun 1;29(16):2247-52. doi: 10.1200/JCO.2010.32.9979. Epub 2011 May 2.

17.

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.

Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH.

Cancer Prev Res (Phila). 2011 Mar;4(3):463-70. doi: 10.1158/1940-6207.CAPR-10-0266. Epub 2011 Jan 28.

18.

A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.

Daniels MS, Burzawa JK, Brandt AC, Schmeler KM, Lu KH.

Fam Cancer. 2011 Jun;10(2):193-7. doi: 10.1007/s10689-011-9418-1.

19.

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH.

Gynecol Oncol. 2011 Feb;120(2):229-32. doi: 10.1016/j.ygyno.2010.10.033. Epub 2010 Dec 3.

PMID:
21126756
20.

Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS.

J Genet Couns. 2011 Feb;20(1):5-19. doi: 10.1007/s10897-010-9325-x. Epub 2010 Oct 8. Review.

PMID:
20931355
21.

Expanding the criteria for BRCA mutation testing in breast cancer survivors.

Kwon JS, Gutierrez-Barrera AM, Young D, Sun CC, Daniels MS, Lu KH, Arun B.

J Clin Oncol. 2010 Sep 20;28(27):4214-20. doi: 10.1200/JCO.2010.28.0719. Epub 2010 Aug 23.

PMID:
20733129
22.

Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.

Schmeler KM, Daniels MS, Soliman PT, Broaddus RR, Deavers MT, Vu TM, Chang GJ, Lu KH.

Obstet Gynecol. 2010 Feb;115(2 Pt 2):432-4. doi: 10.1097/AOG.0b013e3181b6f4f9.

23.

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.

Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH.

Obstet Gynecol. 2010 May;115(5):945-52. doi: 10.1097/AOG.0b013e3181da08d7.

24.

Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome.

Ready KJ, Daniels MS, Sun CC, Peterson SK, Northrup H, Lu KH.

J Cancer Educ. 2010 Sep;25(3):401-4. doi: 10.1007/s13187-010-0063-4.

PMID:
20186516
25.

Preventing future cancers by testing women with ovarian cancer for BRCA mutations.

Kwon JS, Daniels MS, Sun CC, Lu KH.

J Clin Oncol. 2010 Feb 1;28(4):675-82. doi: 10.1200/JCO.2008.21.4684. Epub 2009 Oct 19.

PMID:
19841329
26.

Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome.

Schmeler KM, Daniels MS, Brandt AC, Lu KH.

Obstet Gynecol. 2009 Aug;114(2 Pt 2):477-9. doi: 10.1097/AOG.0b013e31819dade8.

PMID:
19622968
27.

Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.

Daniels MS, Urbauer DL, Stanley JL, Johnson KG, Lu KH.

Genet Med. 2009 Sep;11(9):624-8. doi: 10.1097/GIM.0b013e3181ab2295.

PMID:
19606053
28.

What women with ovarian cancer think and know about genetic testing.

Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA, Kurian S, Webb NF, Pustilnik TB, Lu KH.

Gynecol Oncol. 2008 Oct;111(1):132-6. doi: 10.1016/j.ygyno.2008.06.016. Epub 2008 Aug 6.

29.

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.

Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH.

Cancer. 2008 Jul 15;113(2):326-35. doi: 10.1002/cncr.23554.

30.

Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.

Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RR.

J Clin Oncol. 2007 Nov 20;25(33):5158-64. Epub 2007 Oct 9.

PMID:
17925543
31.

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):515-20.

PMID:
16946209
32.

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH.

N Engl J Med. 2006 Jan 19;354(3):261-9.

33.

Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?

Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH.

J Clin Oncol. 2005 Dec 20;23(36):9344-50.

PMID:
16361634
34.

Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.

Broaddus RR, Lynch HT, Chen LM, Daniels MS, Conrad P, Munsell MF, White KG, Luthra R, Lu KH.

Cancer. 2006 Jan 1;106(1):87-94.

35.

Leveraging of open EMR architecture for clinical trial accrual.

Afrin LB, Oates JC, Boyd CK, Daniels MS.

AMIA Annu Symp Proc. 2003:16-20.

36.

The measurement of hand preference: a validation study comparing three groups of right-handers.

Bishop DV, Ross VA, Daniels MS, Bright P.

Br J Psychol. 1996 May;87 ( Pt 2):269-85.

PMID:
8673359
37.

Social work practice and community health: a planning-implementation model.

Daniels MS.

Soc Work Health Care. 1980 Winter;6(2):39-51.

PMID:
7313915
38.

A proposed network to improve access to high-quality health care for Medicaid-eligible families.

Bosch SJ, Merino R, Daniels MS, Fischer EP, Rosenthal M.

J Community Health. 1979 Summer;4(4):302-11.

PMID:
381337
39.

Sociopsychiatric rehabilitation in a Black urban ghetto. II. Innovative treatment roles and approaches.

Richards H, Daniels MS.

Am J Orthopsychiatry. 1969 Jul;39(4):662-76. No abstract available.

PMID:
5803600

Supplemental Content

Loading ...
Support Center